Search
for
Sort by
Research 31–60 of 1000+
- A family business: stem cell progeny join the niche to regulate homeostasis
- Efficacy and safety of different JAK inhibitors in the treatment of alopecia areata: a network meta-analysis
- JAK-inhibitors in the therapy of comorbid diseases – atopic dermatitis and alopecia areata: literature review and experience of clinical practice
- Treatment of alopecia areata with JAK inhibitors: a review of the literature
- Tofacitinib: The selected selective JAK inhibitor in paediatric dermatology
- 700 Oncostatin M is upstream of JAK-STAT signaling during the murine hair cycle
- JAK kinase pathway inhibitor drugs in patients with moderate-to-severe alopecia: a real-world experience
- El papel de los inhibidores de JAK en la alopecia areata: revisión de la literatura
- TGF-β family signaling in stem cells
- TGFβ family mimetic peptide promotes proliferation of human hair follicle dermal papilla cells and hair growth in C57BL/6 mice
- 801 TEC family kinase inhibitors as a novel class of therapeutics in alopecia areata
- JAK inhibition in the treatment of alopecia areata – a promising new dawn?
- Treatment of severe alopecia areata with baricitinib
- New small molecules in dermatology: for the autoimmunity, inflammation and beyond
- P718 Observational real-world evidence on the efficacy and safety of Janus Kinase inhibitors (JAKi) in the treatment of moderate to severe Active Ulcerative Colitis (UC)
- Small Molecule Inhibitors and Inflammatory Skin Diseases
- Translational Positioning of Janus Kinase (JAK) Inhibitors in Alopecia Areata
- The development of oral hairy leukoplakia during JAK inhibitor baricitinib therapy
- Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition
- JAK inhibitors in dermatology: The promise of a new drug class
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- Tofacitinib Citrate for the Treatment of Nail Dystrophy Associated With Alopecia Universalis
- Developing a JAK Inhibitor for Targeted Local Delivery: Ruxolitinib Cream
- TREMendous Macrophages Inhibit Hair Growth
- Safety of Janus Kinase inhibitors in Patients with Alopecia Areata: A Systematic Review
- Janus Kinase inhibitors in dermatology: a review
- Evidence for the off-label use of tofacitinib in alopecia areata
- A Novel Hope for Alopecia Totalis Patients: Case Report
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata